Sign inGet started

Chen Bihua

Insider CIK 1599214 · EYPT 10% owner · PTI Director, 10% owner · APLS Director, 10% owner · AVIR Director, 10% owner · CRBP 10% owner · TPTX Director, 10% owner · RNA Director, 10% owner · AXNX Director, 10% owner · OKUR 10% owner · KZR Director, 10% owner · BIOA · RXDX Director · AKUS Director, 10% owner · RAIN Director · KNSA Director, 10% owner · OLMA Director, 10% owner · ERAS Director · AARD · PYXS Director · ELEV 10% owner · ICVX · IMRX 10% owner · AVTE · DSGN Director · HLXA CEO and Chairman, Director, 10% owner · GRNA · GLUE 10% owner · BCAB Director, 10% owner · VIGL · DRUG 10% owner · AMAM 10% owner · BLSM Director, 10% owner · BMEA Director, 10% owner · VERV Director · VTYX · TYRA Director · HLXB CEO and Chairperson, Director, 10% owner · AMAM 10% owner · HLXC Chairperson and CEO, Director, 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CRBP Corbus Pharmaceuticals Hol S Sale2026-10-292026-11-02425,000$4.10 $1.74M1,919,971SEC↗
BLSM BlossomHill Therapeutics, C Conversion deriv2026-08-102026-08-101,599,993— $00SEC↗
BLSM BlossomHill Therapeutics, C Conversion deriv2026-08-102026-08-101,701,541— $00SEC↗
BLSM BlossomHill Therapeutics, C Conversion2026-08-102026-08-101,701,541— $03,301,534SEC↗
BLSM BlossomHill Therapeutics, C Conversion2026-08-102026-08-101,599,993— $01,599,993SEC↗
BLSM BlossomHill Therapeutics, P Buy2026-08-102026-08-10312,500$16.00 $5.00M3,614,034SEC↗
BLSM BlossomHill Therapeutics, C Conversion deriv2026-08-102026-08-101,701,541— —0SEC↗
BLSM BlossomHill Therapeutics, C Conversion deriv2026-08-102026-08-101,599,993— —0SEC↗
BLSM BlossomHill Therapeutics, P Buy2026-08-102026-08-10312,500$16.00 $5.00M3,614,034SEC↗
BLSM BlossomHill Therapeutics, C Conversion2026-08-102026-08-101,701,541— —3,301,534SEC↗
BLSM BlossomHill Therapeutics, C Conversion2026-08-102026-08-101,599,993— —1,599,993SEC↗
BLSM BlossomHill Therapeutics, A Award deriv2026-08-062026-08-1023,904— $023,904SEC↗
BLSM BlossomHill Therapeutics, A Award deriv2026-08-062026-08-1023,904— $023,904SEC↗
BBOT BridgeBio Oncology Therape J Other2026-07-012026-07-064,528,186— $00SEC↗
BBOT BridgeBio Oncology Therape J Other2026-07-012026-07-062,692,459— $04,879,995SEC↗
BBOT BridgeBio Oncology Therape J Other2026-07-012026-07-061,704,862— $05,010,332SEC↗
BBOT BridgeBio Oncology Therape J Other2026-07-012026-07-06130,865— $06,083,221SEC↗
BBOT BridgeBio Oncology Therape A Award deriv2026-06-162026-06-1831,675— $031,675SEC↗
DRUG BRIGHT MINDS BIOSCIENCES I S Sale2026-04-282026-04-30109,331$89.50 $9.79M950,000SEC↗
HLXC Helix Acquisition Corp. II A Award2026-01-262026-01-26497,500$10.00 $4.97M497,500SEC↗
HLXC Helix Acquisition Corp. II A Award2026-01-262026-01-28497,500$10.00 $4.97M497,500SEC↗
HLXC Helix Acquisition Corp. II P Buy2026-01-262026-01-28800,000$10.00 $8.00M800,000SEC↗
HLXC Helix Acquisition Corp. II J Other deriv2026-01-222026-01-26718,750— $04,252,500SEC↗
HLXC Helix Acquisition Corp. II J Other deriv2026-01-222026-01-28718,750— $04,252,500SEC↗
CRBP Corbus Pharmaceuticals Hol S Sale2025-12-112025-12-1530,029$11.46 $344.1K2,344,971SEC↗
EYPT EyePoint, Inc. S Sale2025-12-042025-12-0860,000$15.70 $942.0K8,265,000SEC↗
MLTX MoonLake Immunotherapeutic S Sale2025-09-302025-10-015,827$6.96 $40.6K1,994,173SEC↗
MLTX MoonLake Immunotherapeutic S Sale2025-09-292025-10-012,800,000$6.61 $18.51M2,000,000SEC↗
MLTX MoonLake Immunotherapeutic S Sale2025-09-292025-10-013,390,943$7.58 $25.70M4,800,000SEC↗
MLTX MoonLake Immunotherapeutic S Sale2025-09-292025-10-0170,748$9.38 $663.6K8,423,403SEC↗
MLTX MoonLake Immunotherapeutic S Sale2025-09-292025-10-01232,460$8.40 $1.95M8,190,943SEC↗
BBOT BridgeBio Oncology Therape M Exercise deriv2025-08-112025-08-134,172,126— $00SEC↗
BBOT BridgeBio Oncology Therape D To issuer deriv2025-08-112025-08-13307,874— $04,172,126SEC↗
BBOT BridgeBio Oncology Therape A Award2025-08-112025-08-13639,110$10.72 $6.85M1,542,710SEC↗
BBOT BridgeBio Oncology Therape A Award2025-08-112025-08-135,598,425$10.72 $60.02M5,667,785SEC↗
BBOT BridgeBio Oncology Therape A Award2025-08-112025-08-131,905,046— $01,905,046SEC↗
BBOT BridgeBio Oncology Therape A Award2025-08-112025-08-131,762,760— $03,305,470SEC↗
BBOT BridgeBio Oncology Therape A Award2025-08-112025-08-13284,571— $05,952,356SEC↗
BBOT BridgeBio Oncology Therape A Award2025-08-112025-08-13760,496$10.72 $8.15M2,187,536SEC↗
BBOT BridgeBio Oncology Therape M Exercise2025-08-112025-08-134,172,126— $04,681,126SEC↗
BBOT BridgeBio Oncology Therape D To issuer2025-08-112025-08-13152,940— $04,528,186SEC↗
BMEA Biomea Fusion, Inc. A Award deriv2025-06-112025-06-1391,970— $091,970SEC↗
OKUR OnKure Therapeutics, Inc. S Sale2025-05-152025-05-191,813,439$1.85 $3.35M0SEC↗
OKUR OnKure Therapeutics, Inc. S Sale2025-05-122025-05-1424,300$1.99 $48.4K1,813,439SEC↗
AARD Aardvark Therapeutics, Inc C Conversion deriv2025-02-142025-02-196,780,810— $00SEC↗
AARD Aardvark Therapeutics, Inc C Conversion2025-02-142025-02-19800,189— $0800,189SEC↗
AARD Aardvark Therapeutics, Inc P Buy2025-02-142025-02-19187,500$16.00 $3.00M987,689SEC↗
HLXB Helix Acquisition Corp. II J Other deriv2025-02-082025-02-1030,000— $04,480,000SEC↗
DRUG BRIGHT MINDS BIOSCIENCES I P Buy2024-11-042024-11-06184,331$21.70 $4.00M1,059,331SEC↗
DRUG BRIGHT MINDS BIOSCIENCES I P Buy2024-10-162024-10-1739,743$23.22 $922.8K864,743SEC↗
DRUG BRIGHT MINDS BIOSCIENCES I P Buy2024-10-162024-10-173,107$25.22 $78.4K875,000SEC↗
DRUG BRIGHT MINDS BIOSCIENCES I P Buy2024-10-162024-10-177,150$24.03 $171.8K871,893SEC↗
DRUG BRIGHT MINDS BIOSCIENCES I P Buy2024-10-152024-10-174,609$12.35 $56.9K825,000SEC↗
DRUG BRIGHT MINDS BIOSCIENCES I P Buy2024-10-152024-10-1719,169$11.72 $224.7K820,391SEC↗
DRUG BRIGHT MINDS BIOSCIENCES I P Buy2024-10-152024-10-172,700$9.26 $25.0K801,222SEC↗
DRUG BRIGHT MINDS BIOSCIENCES I P Buy2024-10-152024-10-178,900$7.31 $65.1K795,922SEC↗
DRUG BRIGHT MINDS BIOSCIENCES I P Buy2024-10-152024-10-1733,343$6.42 $214.1K787,022SEC↗
DRUG BRIGHT MINDS BIOSCIENCES I P Buy2024-10-152024-10-1763,173$5.92 $374.0K753,679SEC↗
DRUG BRIGHT MINDS BIOSCIENCES I P Buy2024-10-152024-10-17238,097$4.53 $1.08M690,506SEC↗
DRUG BRIGHT MINDS BIOSCIENCES I P Buy2024-10-152024-10-172,600$8.80 $22.9K798,522SEC↗
BIOA BioAge Labs, Inc. C Conversion deriv2024-09-272024-10-015,263,772— $00SEC↗
BIOA BioAge Labs, Inc. C Conversion2024-09-272024-10-011,179,529— $01,179,529SEC↗
BIOA BioAge Labs, Inc. P Buy2024-09-272024-10-01450,000$18.00 $8.10M1,629,529SEC↗
CRBP Corbus Pharmaceuticals Hol P Buy2024-09-202024-09-2447,564$21.47 $1.02M2,349,231SEC↗
CRBP Corbus Pharmaceuticals Hol P Buy2024-09-202024-09-2466,088$19.61 $1.30M2,162,116SEC↗
CRBP Corbus Pharmaceuticals Hol P Buy2024-09-202024-09-24139,551$20.42 $2.85M2,301,667SEC↗
CRBP Corbus Pharmaceuticals Hol P Buy2024-09-202024-09-2425,769$22.23 $572.8K2,375,000SEC↗
CRBP Corbus Pharmaceuticals Hol P Buy2024-09-202024-09-2445,085$17.48 $788.1K2,070,085SEC↗
CRBP Corbus Pharmaceuticals Hol P Buy2024-09-202024-09-2425,943$18.36 $476.3K2,096,028SEC↗
BMEA Biomea Fusion, Inc. A Award deriv2024-06-122024-06-1351,025— $051SEC↗
EYPT EyePoint Pharmaceuticals, P Buy2024-05-062024-05-08642,847$11.70 $7.52M8,117,847SEC↗
EYPT EyePoint Pharmaceuticals, P Buy2024-05-062024-05-08207,153$12.36 $2.56M8,325,000SEC↗
EYPT EyePoint Pharmaceuticals, P Buy2024-04-182024-04-22395,244$17.62 $6.96M7,288,479SEC↗
EYPT EyePoint Pharmaceuticals, P Buy2024-04-182024-04-22186,521$18.90 $3.53M7,475,000SEC↗
IMRX Immuneering Corp S Sale2024-04-012024-04-03100$3.05 $3053,294,773SEC↗
IMRX Immuneering Corp S Sale2024-04-012024-04-03600$3.03 $1.8K3,294,173SEC↗
IMRX Immuneering Corp S Sale2024-04-012024-04-03100$3.07 $3073,295,173SEC↗
IMRX Immuneering Corp S Sale2024-04-012024-04-03300$3.07 $9213,294,873SEC↗
IMRX Immuneering Corp S Sale2024-04-012024-04-03398,600$2.90 $1.16M2,895,273SEC↗
IMRX Immuneering Corp S Sale2024-04-012024-04-0310$3.01 $303,294,163SEC↗
IMRX Immuneering Corp S Sale2024-04-012024-04-0310$2.98 $303,294,153SEC↗
IMRX Immuneering Corp S Sale2024-04-012024-04-03280$2.97 $8323,293,873SEC↗
IMRX Immuneering Corp S Sale2024-03-152024-03-18400,000$2.14 $856.0K3,295,273SEC↗
IMRX Immuneering Corp S Sale2024-03-142024-03-18345,266$3.24 $1.12M3,859,098SEC↗
IMRX Immuneering Corp S Sale2024-03-142024-03-1898,570$4.25 $418.9K3,760,528SEC↗
IMRX Immuneering Corp S Sale2024-03-142024-03-1854,215$5.37 $291.1K3,706,313SEC↗
IMRX Immuneering Corp S Sale2024-03-142024-03-1811,040$5.97 $65.9K3,695,273SEC↗
CRBP Corbus Pharmaceuticals Hol P Buy2024-03-082024-03-1129,342$41.23 $1.21M1,754,342SEC↗
CRBP Corbus Pharmaceuticals Hol P Buy2024-03-082024-03-11156,597$45.26 $7.09M2,016,138SEC↗
CRBP Corbus Pharmaceuticals Hol P Buy2024-03-082024-03-118,862$45.96 $407.3K2,025,000SEC↗
CRBP Corbus Pharmaceuticals Hol P Buy2024-03-082024-03-1118,548$43.26 $802.4K1,797,873SEC↗
CRBP Corbus Pharmaceuticals Hol P Buy2024-03-082024-03-1161,668$44.62 $2.75M1,859,541SEC↗
CRBP Corbus Pharmaceuticals Hol P Buy2024-03-082024-03-1124,983$42.25 $1.06M1,779,325SEC↗
CRBP Corbus Pharmaceuticals Hol P Buy2024-03-072024-03-11102,140$41.23 $4.21M1,725,000SEC↗
CRBP Corbus Pharmaceuticals Hol P Buy2024-03-072024-03-1146,799$37.82 $1.77M1,521,799SEC↗
CRBP Corbus Pharmaceuticals Hol P Buy2024-03-072024-03-1110,736$39.13 $420.1K1,532,535SEC↗
CRBP Corbus Pharmaceuticals Hol P Buy2024-03-072024-03-1190,325$39.99 $3.61M1,622,860SEC↗
HLXB Helix Acquisition Corp. II P Buy2024-02-132024-02-13903,600$10.00 $9.04M903,600SEC↗
HLXB Helix Acquisition Corp. II P Buy2024-02-132024-02-131,427,040$10.00 $14.27M1,427,040SEC↗
HLXB Helix Acquisition Corp. II P Buy2024-02-132024-02-1369,360$10.00 $693.6K69,360SEC↗
HLXB Helix Acquisition Corp. II A Award2024-02-132024-02-13509,000$10.00 $5.09M509,000SEC↗
CRBP Corbus Pharmaceuticals Hol P Buy2024-02-022024-02-06750,000$19.00 $14.25M1,475,000SEC↗
CRBP Corbus Pharmaceuticals Hol P Buy2024-01-262024-01-3016,484$36.53 $602.2K678,046SEC↗
CRBP Corbus Pharmaceuticals Hol P Buy2024-01-262024-01-3032,295$35.83 $1.16M661,562SEC↗
CRBP Corbus Pharmaceuticals Hol P Buy2024-01-262024-01-3031,549$34.62 $1.09M629,267SEC↗
CRBP Corbus Pharmaceuticals Hol P Buy2024-01-262024-01-3018,055$33.71 $608.6K597,718SEC↗
CRBP Corbus Pharmaceuticals Hol P Buy2024-01-262024-01-303,866$32.47 $125.5K579,663SEC↗
CRBP Corbus Pharmaceuticals Hol P Buy2024-01-262024-01-304,125$31.86 $131.4K575,797SEC↗
CRBP Corbus Pharmaceuticals Hol P Buy2024-01-262024-01-302,654$31.00 $82.3K571,672SEC↗
CRBP Corbus Pharmaceuticals Hol P Buy2024-01-262024-01-3043,754$37.49 $1.64M721,800SEC↗
CRBP Corbus Pharmaceuticals Hol P Buy2024-01-262024-01-303,200$38.49 $123.2K725,000SEC↗
CRBP Corbus Pharmaceuticals Hol P Buy2024-01-262024-01-3029,244$29.42 $860.4K569,018SEC↗
CRBP Corbus Pharmaceuticals Hol P Buy2024-01-262024-01-3014,388$25.73 $370.2K456,756SEC↗
CRBP Corbus Pharmaceuticals Hol P Buy2024-01-262024-01-3015,243$26.66 $406.4K471,999SEC↗
CRBP Corbus Pharmaceuticals Hol P Buy2024-01-262024-01-3036,747$27.70 $1.02M508,746SEC↗
CRBP Corbus Pharmaceuticals Hol P Buy2024-01-262024-01-3031,028$28.82 $894.2K539,774SEC↗
EYPT EyePoint Pharmaceuticals, P Buy2024-01-112024-01-11750,000$19.75 $14.81M6,893,235SEC↗
EYPT EyePoint Pharmaceuticals, P Buy2024-01-092024-01-11105,000$21.32 $2.24M6,143,235SEC↗
EYPT EyePoint Pharmaceuticals, P Buy2023-12-082023-12-12588,235$17.00 $10.00M6,038,235SEC↗
EYPT EyePoint Pharmaceuticals, P Buy2023-12-042023-12-0619,866$33.75 $670.5K5,441,740SEC↗
EYPT EyePoint Pharmaceuticals, P Buy2023-12-042023-12-0641,824$33.08 $1.38M5,421,874SEC↗
EYPT EyePoint Pharmaceuticals, P Buy2023-12-042023-12-068,260$34.49 $284.9K5,450,000SEC↗
EYPT EyePoint Pharmaceuticals, P Buy2023-12-042023-12-06321,259$18.80 $6.04M3,852,202SEC↗
EYPT EyePoint Pharmaceuticals, P Buy2023-12-042023-12-0686,713$31.83 $2.76M5,380,050SEC↗
EYPT EyePoint Pharmaceuticals, P Buy2023-12-042023-12-0615,582$30.74 $479.0K5,293,337SEC↗
EYPT EyePoint Pharmaceuticals, P Buy2023-12-042023-12-0618,601$29.91 $556.4K5,277,755SEC↗
EYPT EyePoint Pharmaceuticals, P Buy2023-12-042023-12-068,168$28.78 $235.1K5,259,154SEC↗
EYPT EyePoint Pharmaceuticals, P Buy2023-12-042023-12-0627,425$27.87 $764.3K5,250,986SEC↗
EYPT EyePoint Pharmaceuticals, P Buy2023-12-042023-12-0653,109$26.73 $1.42M5,223,561SEC↗
EYPT EyePoint Pharmaceuticals, P Buy2023-12-042023-12-0665,086$25.88 $1.68M5,170,452SEC↗
EYPT EyePoint Pharmaceuticals, P Buy2023-12-042023-12-0639,899$24.87 $992.3K5,105,366SEC↗
EYPT EyePoint Pharmaceuticals, P Buy2023-12-042023-12-0637,081$24.01 $890.3K5,065,467SEC↗
EYPT EyePoint Pharmaceuticals, P Buy2023-12-042023-12-0628,090$22.80 $640.5K5,028,386SEC↗
EYPT EyePoint Pharmaceuticals, P Buy2023-12-042023-12-0679,805$21.87 $1.75M5,000,296SEC↗
EYPT EyePoint Pharmaceuticals, P Buy2023-12-042023-12-06122,625$20.62 $2.53M4,920,491SEC↗
EYPT EyePoint Pharmaceuticals, P Buy2023-12-042023-12-06945,664$19.88 $18.80M4,797,866SEC↗
AMAM Ambrx Biopharma, Inc. P Buy2023-10-232023-10-251,307,311$6.99 $9.14M11,231,000SEC↗
MLTX MoonLake Immunotherapeutic P Buy2023-10-052023-10-1058,839$59.90 $3.52M8,494,151SEC↗
MLTX MoonLake Immunotherapeutic P Buy2023-10-042023-10-0467,814$57.32 $3.89M8,435,312SEC↗
MLTX MoonLake Immunotherapeutic P Buy2023-10-032023-10-04150,487$57.25 $8.62M8,367,498SEC↗
MLTX MoonLake Immunotherapeutic P Buy2023-10-022023-10-0474,911$57.37 $4.30M8,217,011SEC↗
AMAM Ambrx Biopharma Inc. P Buy2023-09-182023-09-19751,233$9.24 $6.94M69,465,823SEC↗
AMAM Ambrx Biopharma Inc. P Buy2023-09-152023-09-191,401,505$9.05 $12.68M68,714,590SEC↗
GRNA GreenLight Biosciences Hol S Sale2023-07-202023-07-249,188,659— $00SEC↗
MLTX MoonLake Immunotherapeutic P Buy2023-06-302023-07-05800,000$50.00 $40.00M4,927,100SEC↗
MLTX MoonLake Immunotherapeutic P Buy2023-06-262023-06-2821,823$53.98 $1.18M4,102,304SEC↗
MLTX MoonLake Immunotherapeutic P Buy2023-06-262023-06-284,725$52.81 $249.5K4,080,481SEC↗
MLTX MoonLake Immunotherapeutic P Buy2023-06-262023-06-288,697$52.01 $452.3K4,075,756SEC↗
MLTX MoonLake Immunotherapeutic P Buy2023-06-262023-06-2817,662$50.77 $896.7K4,067,059SEC↗
MLTX MoonLake Immunotherapeutic P Buy2023-06-262023-06-2859,787$49.82 $2.98M4,049,397SEC↗
MLTX MoonLake Immunotherapeutic P Buy2023-06-262023-06-2837,783$48.93 $1.85M3,989,610SEC↗
MLTX MoonLake Immunotherapeutic P Buy2023-06-262023-06-2810,946$44.93 $491.8K3,951,827SEC↗
MLTX MoonLake Immunotherapeutic P Buy2023-06-262023-06-2831,558$44.23 $1.40M3,940,881SEC↗
MLTX MoonLake Immunotherapeutic P Buy2023-06-262023-06-2866,087$43.30 $2.86M3,909,323SEC↗
MLTX MoonLake Immunotherapeutic P Buy2023-06-262023-06-2861,042$42.12 $2.57M3,843,236SEC↗
MLTX MoonLake Immunotherapeutic P Buy2023-06-262023-06-2850,642$41.03 $2.08M3,782,194SEC↗
MLTX MoonLake Immunotherapeutic P Buy2023-06-262023-06-2838,623$39.87 $1.54M3,731,552SEC↗
MLTX MoonLake Immunotherapeutic P Buy2023-06-262023-06-2810,593$39.17 $414.9K3,692,929SEC↗
MLTX MoonLake Immunotherapeutic P Buy2023-06-262023-06-283,755$38.18 $143.4K3,682,336SEC↗
MLTX MoonLake Immunotherapeutic P Buy2023-06-262023-06-281,481$36.91 $54.7K3,678,581SEC↗
MLTX MoonLake Immunotherapeutic P Buy2023-06-262023-06-2885$72.46 $6.2K4,127,100SEC↗
MLTX MoonLake Immunotherapeutic P Buy2023-06-262023-06-2815$70.62 $1.1K4,127,015SEC↗
MLTX MoonLake Immunotherapeutic P Buy2023-06-262023-06-2816$65.32 $1.0K4,127,000SEC↗
MLTX MoonLake Immunotherapeutic P Buy2023-06-262023-06-2895$64.44 $6.1K4,126,984SEC↗
MLTX MoonLake Immunotherapeutic P Buy2023-06-262023-06-28139$63.85 $8.9K4,126,889SEC↗
MLTX MoonLake Immunotherapeutic P Buy2023-06-262023-06-28136$62.20 $8.5K4,126,750SEC↗
MLTX MoonLake Immunotherapeutic P Buy2023-06-262023-06-28417$60.21 $25.1K4,126,614SEC↗
MLTX MoonLake Immunotherapeutic P Buy2023-06-262023-06-281,302$58.98 $76.8K4,126,197SEC↗
MLTX MoonLake Immunotherapeutic P Buy2023-06-262023-06-28295$57.63 $17.0K4,124,895SEC↗
MLTX MoonLake Immunotherapeutic P Buy2023-06-262023-06-281,894$56.89 $107.7K4,124,600SEC↗
MLTX MoonLake Immunotherapeutic P Buy2023-06-262023-06-281,453$55.83 $81.1K4,122,706SEC↗
MLTX MoonLake Immunotherapeutic P Buy2023-06-262023-06-2818,949$54.92 $1.04M4,121,253SEC↗
ERAS Erasca, Inc. A Award deriv2023-06-222023-06-2660,000— $060,000SEC↗
BMEA Biomea Fusion, Inc. A Award deriv2023-06-142023-06-166,989— $06,989SEC↗
AMAM Ambrx Biopharma Inc. P Buy2023-04-202023-04-20886,634$11.60 $10.28M67,313,085SEC↗
AMAM Ambrx Biopharma Inc. P Buy2023-04-192023-04-20951,909$11.15 $10.61M66,426,451SEC↗
AMAM Ambrx Biopharma Inc. P Buy2023-04-182023-04-203,376,646$11.27 $38.05M65,474,542SEC↗
AMAM Ambrx Biopharma Inc. P Buy2023-04-172023-04-17562,121$10.67 $6.00M62,097,896SEC↗
AMAM Ambrx Biopharma Inc. P Buy2023-04-142023-04-17841,967$9.96 $8.39M61,535,775SEC↗
AMAM Ambrx Biopharma Inc. P Buy2023-04-132023-04-171,193,808$9.16 $10.94M60,693,808SEC↗
BMEA Biomea Fusion, Inc. P Buy2023-03-302023-04-03400,000$30.00 $12.00M3,570,872SEC↗
MLTX MoonLake Immunotherapeutic P Buy2023-03-212023-03-22238,511$21.70 $5.18M3,677,100SEC↗
MLTX MoonLake Immunotherapeutic P Buy2023-03-202023-03-22446,881$19.36 $8.65M3,296,881SEC↗
MLTX MoonLake Immunotherapeutic P Buy2023-03-202023-03-2263,700$20.42 $1.30M3,360,581SEC↗
MLTX MoonLake Immunotherapeutic P Buy2023-03-202023-03-2278,008$21.08 $1.64M3,438,589SEC↗
AMAM Ambrx Biopharma Inc. P Buy2023-03-162023-03-16500,000$10.15 $5.08M53,500,000SEC↗
AMAM Ambrx Biopharma Inc. P Buy2023-03-152023-03-16250,000$10.60 $2.65M53,000,000SEC↗
AMAM Ambrx Biopharma Inc. P Buy2023-03-142023-03-16250,000$9.95 $2.49M52,750,000SEC↗
ERAS Erasca, Inc. P Buy2022-12-132022-12-20307,692$6.50 $2.00M10,813,246SEC↗
ERAS Erasca, Inc. P Buy2022-12-132022-12-21307,692$6.50 $2.00M10,813,246SEC↗
BMEA Biomea Fusion, Inc. A Award deriv2022-06-222022-06-2423,867— $023,867SEC↗
ERAS Erasca, Inc. A Award deriv2022-06-222022-06-2440,000— $040,000SEC↗
MLTX MoonLake Immunotherapeutic C Conversion deriv2022-04-052022-04-072,785,000— $00SEC↗
MLTX MoonLake Immunotherapeutic C Conversion2022-04-052022-04-072,785,000— $03,215,000SEC↗
MLTX MoonLake Immunotherapeutic P Buy2022-04-052022-04-072,850,000$10.00 $28.50M2,850,000SEC↗
VIGL Vigil Neuroscience, Inc. C Conversion deriv2022-01-112022-01-13616,786— $00SEC↗
VIGL Vigil Neuroscience, Inc. C Conversion2022-01-112022-01-13616,786— $0616,786SEC↗
VTYX Ventyx Biosciences, Inc. C Conversion deriv2021-10-252021-10-27548,288— $00SEC↗
VTYX Ventyx Biosciences, Inc. C Conversion deriv2021-10-252021-10-27237,015— $00SEC↗
VTYX Ventyx Biosciences, Inc. C Conversion2021-10-252021-10-27785,303— $0785,303SEC↗
VTYX Ventyx Biosciences, Inc. P Buy2021-10-252021-10-27625,000$16.00 $10.00M1,410,303SEC↗
PYXS Pyxis Oncology, Inc. C Conversion deriv2021-10-132021-10-15668,854— $00SEC↗
PYXS Pyxis Oncology, Inc. C Conversion2021-10-132021-10-15668,854— $0668,854SEC↗
PYXS Pyxis Oncology, Inc. P Buy2021-10-132021-10-15450,000$16.00 $7.20M1,118,854SEC↗
TYRA Tyra Biosciences, Inc. C Conversion deriv2021-09-172021-09-21757,432— $00SEC↗
TYRA Tyra Biosciences, Inc. C Conversion2021-09-172021-09-21757,432— $0757,432SEC↗
TYRA Tyra Biosciences, Inc. P Buy2021-09-172021-09-21312,500$16.00 $5.00M1,069,932SEC↗
ERAS Erasca, Inc. P Buy2021-08-102021-08-10200,000$22.10 $4.42M10,505,553SEC↗
IMRX Immuneering Corp C Conversion deriv2021-08-032021-08-051,702,628— $00SEC↗
IMRX Immuneering Corp P Buy2021-08-032021-08-05550,000$15.00 $8.25M2,252,628SEC↗
IMRX Immuneering Corp C Conversion2021-08-032021-08-051,702,628— $01,702,628SEC↗
ICVX Icosavax, Inc. C Conversion deriv2021-08-022021-08-04426,393— $00SEC↗
ICVX Icosavax, Inc. C Conversion2021-08-022021-08-04426,393— $0426,393SEC↗
ERAS Erasca, Inc. S Sale2021-07-262021-08-10200,000$18.77 $3.75M10,305,553SEC↗
ERAS Erasca, Inc. C Conversion deriv2021-07-202021-07-224,000,000— $00SEC↗
ERAS Erasca, Inc. C Conversion deriv2021-07-202021-07-221,388,887— $00SEC↗
ERAS Erasca, Inc. C Conversion deriv2021-07-202021-07-224,166,666— $00SEC↗
ERAS Erasca, Inc. P Buy2021-07-202021-07-22950,000$16.00 $15.20M10,505,553SEC↗
ERAS Erasca, Inc. C Conversion2021-07-202021-07-229,555,553— $09,555,553SEC↗
AVTE Aerovate Therapeutics, Inc C Conversion deriv2021-07-022021-07-071,530,691— $00SEC↗
AVTE Aerovate Therapeutics, Inc P Buy2021-07-022021-07-07500,000$14.00 $7.00M2,030,691SEC↗
AVTE Aerovate Therapeutics, Inc C Conversion2021-07-022021-07-071,530,691— $01,530,691SEC↗
ELEV Elevation Oncology, Inc. C Conversion deriv2021-06-292021-07-011,983,168— $00SEC↗
ELEV Elevation Oncology, Inc. P Buy2021-06-292021-07-01250,000$16.00 $4.00M2,233,168SEC↗
ELEV Elevation Oncology, Inc. C Conversion2021-06-292021-07-011,983,168— $01,983,168SEC↗
GLUE Monte Rosa Therapeutics, I C Conversion deriv2021-06-282021-06-302,124,343— $00SEC↗
GLUE Monte Rosa Therapeutics, I C Conversion deriv2021-06-282021-06-30477,857— $00SEC↗
GLUE Monte Rosa Therapeutics, I P Buy2021-06-282021-06-30600,000$19.00 $11.40M3,202,200SEC↗
GLUE Monte Rosa Therapeutics, I C Conversion2021-06-282021-06-302,602,200— $02,602,200SEC↗
VERV Verve Therapeutics, Inc. C Conversion deriv2021-06-212021-06-23709,224— $00SEC↗
VERV Verve Therapeutics, Inc. C Conversion2021-06-212021-06-23709,224— $0709,224SEC↗
VERV Verve Therapeutics, Inc. P Buy2021-06-212021-06-23275,000$19.00 $5.22M984,224SEC↗
RAIN Rain Therapeutics Inc. C Conversion deriv2021-04-272021-04-292,512,561— $00SEC↗
RAIN Rain Therapeutics Inc. P Buy2021-04-272021-04-29450,000$17.00 $7.65M2,776,657SEC↗
RAIN Rain Therapeutics Inc. C Conversion2021-04-272021-04-292,326,657— $02,326,657SEC↗
BMEA Biomea Fusion, Inc. C Conversion deriv2021-04-202021-04-222,270,872— $00SEC↗
BMEA Biomea Fusion, Inc. P Buy2021-04-202021-04-22900,000$17.00 $15.30M3,170,872SEC↗
BMEA Biomea Fusion, Inc. C Conversion2021-04-202021-04-222,270,872— $02,270,872SEC↗
BMEA Biomea Fusion, Inc. A Award deriv2021-04-152021-04-1928,911— $028,911SEC↗
DSGN Design Therapeutics, Inc. C Conversion deriv2021-03-302021-04-011,404,953— $00SEC↗
DSGN Design Therapeutics, Inc. C Conversion deriv2021-03-302021-04-012,959,891— $00SEC↗
DSGN Design Therapeutics, Inc. C Conversion2021-03-302021-04-014,364,844— $04,364,844SEC↗
DSGN Design Therapeutics, Inc. P Buy2021-03-302021-04-01750,000$20.00 $15.00M5,114,844SEC↗
RXDX Prometheus Biosciences, In C Conversion deriv2021-03-162021-03-18763,327— $00SEC↗
RXDX Prometheus Biosciences, In C Conversion deriv2021-03-162021-03-181,084,696— $00SEC↗
RXDX Prometheus Biosciences, In C Conversion2021-03-162021-03-181,848,022— $01,848,022SEC↗
RXDX Prometheus Biosciences, In P Buy2021-03-162021-03-18375,000$19.00 $7.13M2,223,022SEC↗
BCAB BioAtla, Inc. C Conversion deriv2020-12-182020-12-221,492,060— $00SEC↗
BCAB BioAtla, Inc. C Conversion2020-12-182020-12-221,492,060— $01,492,060SEC↗
BCAB BioAtla, Inc. P Buy2020-12-182020-12-22800,000$18.00 $14.40M2,292,060SEC↗
OLMA Olema Pharmaceuticals, Inc C Conversion deriv2020-11-232020-11-23723,177— $00SEC↗
OLMA Olema Pharmaceuticals, Inc C Conversion deriv2020-11-232020-11-232,122,367— $00SEC↗
OLMA Olema Pharmaceuticals, Inc C Conversion2020-11-232020-11-232,845,544— $02,845,544SEC↗
OLMA Olema Pharmaceuticals, Inc P Buy2020-11-232020-11-23425,000$19.00 $8.07M3,270,544SEC↗
AVIR Atea Pharmaceuticals, Inc. C Conversion deriv2020-11-032020-11-052,631,580— $00SEC↗
AVIR Atea Pharmaceuticals, Inc. C Conversion deriv2020-11-032020-11-05712,250— $00SEC↗
AVIR Atea Pharmaceuticals, Inc. C Conversion deriv2020-11-032020-11-051,650,165— $00SEC↗
AVIR Atea Pharmaceuticals, Inc. C Conversion deriv2020-11-032020-11-051,000,000— $00SEC↗
AVIR Atea Pharmaceuticals, Inc. C Conversion deriv2020-11-032020-11-05417,360— $00SEC↗
AVIR Atea Pharmaceuticals, Inc. C Conversion2020-11-032020-11-056,411,355— $06,411,355SEC↗
HLXA Helix Acquisition Corp P Buy2020-10-222020-10-22430,000$10.00 $4.30M430,000SEC↗
AKUS Akouos, Inc. C Conversion deriv2020-06-302020-07-02499,989— $00SEC↗
AKUS Akouos, Inc. P Buy2020-06-302020-07-02290,000$17.00 $4.93M789,989SEC↗
AKUS Akouos, Inc. C Conversion2020-06-302020-07-02499,989— $0499,989SEC↗
RNA Avidity Biosciences, Inc. C Conversion deriv2020-06-162020-06-182,214,545— $00SEC↗
RNA Avidity Biosciences, Inc. C Conversion2020-06-162020-06-182,214,545— $02,214,545SEC↗
RNA Avidity Biosciences, Inc. P Buy2020-06-162020-06-18300,000$18.00 $5.40M2,514,545SEC↗
TPTX Turning Point Therapeutics M Exercise2019-05-142019-05-1623,268$2.19 $51.0K3,122,367SEC↗
TPTX Turning Point Therapeutics M Exercise deriv2019-05-132019-05-1623,268— $00SEC↗
TPTX Turning Point Therapeutics P Buy2019-04-222019-04-25400,000$18.00 $7.20M3,099,099SEC↗
AXNX Axonics Modulation Technol C Conversion deriv2018-10-312018-11-02599,999— $00SEC↗
AXNX Axonics Modulation Technol C Conversion deriv2018-10-312018-11-02552,495— $00SEC↗
AXNX Axonics Modulation Technol C Conversion2018-10-312018-11-02552,495— $01,152,494SEC↗
AXNX Axonics Modulation Technol P Buy2018-10-312018-11-02133,333$15.00 $2.00M1,285,827SEC↗
AXNX Axonics Modulation Technol C Conversion2018-10-312018-11-02599,999— $0599,999SEC↗
KZR Kezar Life Sciences, Inc. C Conversion deriv2018-06-252018-06-27315,488— $00SEC↗
KZR Kezar Life Sciences, Inc. C Conversion deriv2018-06-252018-06-271,007,421— $00SEC↗
KZR Kezar Life Sciences, Inc. C Conversion2018-06-252018-06-27315,488— $0315,488SEC↗
KZR Kezar Life Sciences, Inc. P Buy2018-06-252018-06-27250,000$15.00 $3.75M1,572,909SEC↗
KZR Kezar Life Sciences, Inc. C Conversion2018-06-252018-06-271,007,421— $01,322,909SEC↗
KNSA Kiniksa Pharmaceuticals, L C Conversion deriv2018-05-292018-05-31830,999— $00SEC↗
KNSA Kiniksa Pharmaceuticals, L C Conversion2018-05-292018-05-31830,999— $0830,999SEC↗
KNSA Kiniksa Pharmaceuticals, L P Buy2018-05-292018-05-3169,444$18.00 $1.25M900,443SEC↗
PTI PROTEOSTASIS THERAPEUTICS, S Sale2017-12-142017-12-18504,027$4.88 $2.46M3,300,000SEC↗
APLS Apellis Pharmaceuticals, I C Conversion deriv2017-11-132017-11-142,098,581— $00SEC↗
APLS Apellis Pharmaceuticals, I C Conversion deriv2017-11-132017-11-14303,916— $00SEC↗
APLS Apellis Pharmaceuticals, I P Buy2017-11-132017-11-141,071,428$14.00 $15.00M3,473,925SEC↗
APLS Apellis Pharmaceuticals, I C Conversion2017-11-132017-11-142,402,497— $02,402,497SEC↗
PTI PROTEOSTASIS THERAPEUTICS, P Buy2016-12-132016-12-1421,301$10.98 $233.9K3,804,027SEC↗
PTI PROTEOSTASIS THERAPEUTICS, P Buy2016-12-122016-12-14100,000$10.79 $1.08M3,782,726SEC↗
PTI PROTEOSTASIS THERAPEUTICS, P Buy2016-12-082016-12-0921,819$10.93 $238.5K3,682,726SEC↗
PTI PROTEOSTASIS THERAPEUTICS, P Buy2016-12-072016-12-0922,598$10.74 $242.7K3,660,907SEC↗
PTI PROTEOSTASIS THERAPEUTICS, P Buy2016-12-062016-12-068,216$10.89 $89.5K3,638,309SEC↗
PTI PROTEOSTASIS THERAPEUTICS, P Buy2016-12-052016-12-0629,757$10.78 $320.8K3,630,093SEC↗
PTI PROTEOSTASIS THERAPEUTICS, P Buy2016-12-022016-12-0650,000$10.48 $524.0K3,600,336SEC↗
PTI PROTEOSTASIS THERAPEUTICS, P Buy2016-12-012016-12-0141,984$10.11 $424.5K3,550,336SEC↗
PTI PROTEOSTASIS THERAPEUTICS, P Buy2016-11-292016-12-01128,407$10.28 $1.32M3,508,352SEC↗
PTI PROTEOSTASIS THERAPEUTICS, P Buy2016-11-232016-11-23180,300$11.37 $2.05M3,379,745SEC↗
PTI PROTEOSTASIS THERAPEUTICS, P Buy2016-11-232016-11-23200$10.67 $2.1K3,379,945SEC↗
PTI PROTEOSTASIS THERAPEUTICS, P Buy2016-11-222016-11-2369,500$11.08 $770.1K3,199,445SEC↗